Systematic reviews on corona disease 2019 (COVID-19)
COVID-19 (coronavirus disease 2019) is a public health emergency of international concern. As of this time, there is very limited data available on almost all aspects of this disease.
We are refocussing our work to provide rapid systematic reviews on COVID-19. In the first place we will focus on risk factors for prognosis, risk factors for incidence and the effectiveness of new interventions.
We are looking for colleagues with experience in systematic reviews to help us, specifically those with expertise literature searching of pre-print journals and archives, critical appraisal and meta-analyses in stata.
If you are interested please contact m.zeegers@maastrichtuniversity.nl
Also read
-
Is the risk of cancer the same for everyone?
Valery Lemmens (GROW) conducts research on cancer, prevention, and how society is designed for making unhealthy choices.
-
Most prestigious European grant to two UM scientists
Two Maastricht University professors are to receive the most prestigious European research grant for individual researchers: an ERC Advanced Grant, worth over €2.5 million. They are Lorenzo Moroni (MERLN) and Alexander Sack (FPN).
-
A new outlook on rehabilitation care
Ivan Huijnen (CAPHRI) aims to shift from the biomedical 'disorder-focused' thinking to an integral view on healthcare.
